AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2017
Apr 6, 2017
30237_dirs_2017-04-06_115d0bfe-1b0b-4180-bd23-82f4985b24f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2017-04-04
Reporting Person: Gary M. Huff (CEO, LabCorp Diagnostics)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-04 | Restricted Stock Unit | $ | A | 1890 | Acquired | Common Stock (1890) | Direct | |
| 2017-04-04 | Restricted Stock Unit | $ | A | 10500 | Acquired | Common Stock (10500) | Direct |
Footnotes
F1: Each restricted stock unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vest in three equal annual installments beginning on 2/7/18.
F3: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
F4: The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18.
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Declaration of Voting Results & Voting Rights Announcements
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Earnings Release
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Notice of Dividend Amount
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30